Cross Country Healthcare, Inc. (CCRN)
Jul 21, 2026 - CCRN was delisted (reason: acquired by Knox Lane)
13.25
0.00 (0.00%)
Inactive · Last trade price on Jul 20, 2026

Cross Country Healthcare Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-98.63-94.85-14.5672.63185.98132
Depreciation & Amortization
14.8915.9917.517.8511.989.45
Other Amortization
0.80.80.70.50.60.4
Asset Writedown & Restructuring Costs
78.0877.852.890.725.62.07
Stock-Based Compensation
77.146.036.587.396.89
Other Operating Activities
11.7910.8519.9322.7526.220.82
Change in Accounts Receivable
44.156.73128.33251.43-153.23-318.42
Change in Accounts Payable
-11.76-34.57-29.75-126.6182.9483.29
Change in Income Taxes
3.187.18-2.286.96-20.917.49
Change in Other Net Operating Assets
-2.121.13-8.67-4.29-12.52-9.61
Operating Cash Flow
47.3448.25120.12248.5134.05-85.62
Operating Cash Flow Growth
-60.48%-59.83%-51.66%85.38%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.73-8.16-8.71-13.97-8.79-7.17
Cash Acquisitions
---0.2-35.09-26.88
Investing Cash Flow
-7.73-8.16-8.71-13.78-43.87-34.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1.4518.02720.991,700618.54
Total Debt Issued
1.451.4518.02720.991,700618.54
Long-Term Debt Repaid
--1.45-18.02-871.67-1,735-490.87
Total Debt Repaid
-1.45-1.45-18.02-871.67-1,735-490.87
Net Debt Issued (Repaid)
----150.68-35.26127.68
Repurchase of Common Stock
-14.74-8.6-40.27-62.56-40.55-2.23
Other Financing Activities
--4.41-6.58-8.01-11.78-6.35
Financing Cash Flow
-14.74-13.01-46.85-221.24-87.6119.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.020.02-0.010.01-0.010.01
Net Cash Flow
24.8927.1164.5413.492.57-0.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
39.640.09111.4234.52125.26-92.79
Free Cash Flow Growth
-64.45%-64.01%-52.50%87.22%--
Free Cash Flow Margin
3.95%3.80%8.29%11.61%4.47%-5.53%
Free Cash Flow Per Share
1.231.243.346.613.34-2.48
Levered Free Cash Flow
47.0942.77124.95236.6787.15-124.74
Unlevered Free Cash Flow
48.4944.16126.31241.7396.15-120.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.41.41.377.5312.865.77
Cash Income Tax Paid
--5.692.4321.9982.893.61
Change in Working Capital
33.430.4787.63127.48-103.71-237.26
SEC Filings: 10-K · 10-Q